News

David Nanus, M.D., and Scott Tagawa, M.D., M.S., speak to Fox 5 News about liquid biopsies in cancer treatment. Read more

A phase II trial reported in the Journal of Clinical Oncolo gy by John P. Leonard, M.D., and collaborators showed no significant progression-free survival benefit of adding bortezomib to R-CHOP. Read more

Dr. Olivier Elemento , a renowned computational biologist and leader in the field of computational genomics and biomedicine, has been named director of the Caryl and Israel Englander Institute for Precision Medicine at Weill... Read more

NEW YORK (September 7, 2017) — Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI), part of the National... Read more

Brendon Stiles, M.D., reflects on his experience with an inspiring young patient. Read more

An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a study by Ithaca member John Schimenti, Ph.D. Read more

Feature about Lorraine Gudas, Ph.D., who is studying the role of Vitamin A and retinoic acid in cancer and other diseases. Read more

Ashish Saxena, M.D., Ph.D., comments on the results of a study on the use of immunotherapy to treat patients with the lung cancer mesothelioma. Read more

John P. Leonard, M.D., discusses the advance of precision medicine across hematologic malignancies. Read more